Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
Adv Exp Med Biol. 2018;1074:247-255. doi: 10.1007/978-3-319-75402-4_30.
Age-related macular degeneration (AMD) is a complex disease with both environmental and genetic factors influencing disease risk. Genome-wide case-control association studies, candidate gene analyses, and epidemiological studies reinforced the notion that AMD is predominantly a disease of an impaired complement system and an altered high-density lipoprotein (HDL) metabolism. Recent reports demonstrated the pleiotropic role of the complement system and HDL in complex diseases such as cardiovascular disease, autoimmune disorders, cancer, and Alzheimer's disease. In light of these findings, we explore current evidence for a shared genetic and environmental risk of AMD and unrelated complex diseases based on epidemiological studies. Shared risk factors may indicate common pathways in disease pathology and thus may have implications for novel treatment options of AMD pathology.
年龄相关性黄斑变性(AMD)是一种复杂的疾病,环境和遗传因素都会影响疾病的风险。全基因组病例对照关联研究、候选基因分析和流行病学研究都证实了 AMD 主要是一种补体系统受损和高密度脂蛋白(HDL)代谢异常的疾病。最近的报告表明,补体系统和 HDL 在心血管疾病、自身免疫性疾病、癌症和阿尔茨海默病等复杂疾病中具有多效性作用。有鉴于此,我们根据流行病学研究探讨了 AMD 和无关联的复杂疾病的遗传和环境风险的共同证据。共同的危险因素可能表明疾病病理中的共同途径,因此可能对 AMD 病理的新治疗选择具有影响。